IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Actavis Acquires Chinese Manufacturer

9:26 AM MDT | April 21, 2008 | DR

Generics pharmaceutical manufacturer, Actavis (Hafnarfjordur, Iceland) says it has acquired 90% of active pharma ingredient (API) producer Zhejiang Chiral Medicine Chemicals Co. (Hangzhou, China). Terms of the deal were not disclosed. Actavis says the acquisition is part of its strategy to obtain direct access to low-cost API manufacturing. Wessman: Access to low-cost production. “This new facility will enable Actavis to further reduce its manufacturing costs and is an important extension of our activities in China,” says Robert Wessman, president and...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa